M1 Kliniken AG (MKLNF) Comparison with companies in other sectors?

M1 Kliniken AG has a share price of 18.56M. You can analyze M1 Kliniken AG (MKLNF) competitors across different market sectors through stock heatmaps.

What are MKLNF's NET and operating margins?

M1 Kliniken AG (MKLNF) operating margin is around 0.09, and net profit margin is approximately 0.06 as of the latest reports.

In what way does MKLNF's earnings per share (EPS) trend reflect its financial momentum?

M1 Kliniken AG (MKLNF) EPS is 0.61 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for M1 Kliniken AG is 19.23, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for M1 Kliniken AG?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for M1 Kliniken AG like P/E which is 12.56, P/B which is 1.76, and PEG which is 0.45. Compare them with sector averages to evaluate if the stock is priced fairly.

M1 Kliniken AG

MKLNF•PNK

Healthcare

Medical - Care Facilities

$11.73

$0.00(0.00%)

Fundamental Analysis of M1 Kliniken AG (MKLNF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.61

P/E Ratio

19.23

ROE

0.14%

Net Margin

0.06%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$217.62M

Shares OutstandingTotal number of shares issued

$18.56M

Book Value/ShareNet worth per share

$7.19

Revenue/ShareAnnual revenue per share

$13.47

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.61

Net MarginNet income as percentage of revenue

5.90%

Operating MarginOperating income as percentage of revenue

8.63%

ROEReturn on shareholders' equity

13.71%

ROAReturn on total assets

7.90%

ROCEReturn on capital employed

15.06%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.16

Cash/ShareCash and equivalents per share

$1.27

FCF YieldFree cash flow as percentage of market cap

11.73%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.50

Dividend YieldAnnual dividend as percentage of stock price

5.009%

Financial Ratios Analysis data is not available for MKLNFFinancial Ratios Analysis details for MKLNF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MKLNFSector Benchmarking details for MKLNF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for M1 Kliniken AG Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of M1 Kliniken AG. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account M1 Kliniken AG's unique business strengths and challenges.

Key Financial Metrics for M1 Kliniken AG

For M1 Kliniken AG, essential financial indicators include EPS 0.61, PE 19.23, and ROE 0.14. These key ratios reveal insights into M1 Kliniken AG's profitability, valuation, and operational health. Understanding these metrics enables you to compare M1 Kliniken AG with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of M1 Kliniken AG

Metrics like Net Margin 5.90% and ROA 7.90% shed light on how well M1 Kliniken AG is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether M1 Kliniken AG can sustain its operations and continue growing in the future.

Valuation and Market Position of M1 Kliniken AG

Using ratios such as P/B Ratio 1.76 and PEG Ratio 0.45, investors can assess whether M1 Kliniken AG is appropriately valued based on its financials and growth potential. These figures, combined with M1 Kliniken AG's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for M1 Kliniken AG

Financial health indicators, such as Debt/Equity Ratio 0.10 and Cash Flow $1.16, provide a snapshot of M1 Kliniken AG's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like M1 Kliniken AG, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for M1 Kliniken AG

Investing in M1 Kliniken AG based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at M1 Kliniken AG focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;